Study | Country | Design | Prosthesis types | Operation type | Patients/Knees | Male/Female | Age(years) | Outcomes | Mean Follow-up(months) | |
---|---|---|---|---|---|---|---|---|---|---|
Asymmetrical | Symmetric | |||||||||
Koster LA et al., 2021 [10] | Netherlands | RCT | Persona | NexGen | Actual TKA | 31/31 38/38 | 13/19 16/22 | 63.8 ± 12.0 67.3 ± 8.0 | Revision rate | 24 |
Minoda Y et al., 2017 [11] | Japan | RCT | Advance medial pivot | Evolution medial pivot | Actual TKA | 31/31a | 2/29a | 69 ± 13a | Overhang | None |
Indelli PF et al., 2015 [12] | USA | RCT | Persona | NexGen | Actual TKA | 40/40 40/40 | 16/24 15/25 | 71(66–80)b 72(60–81)b | Rotation of the tibial component; Revision rate; Clinical outcomes (Anterior knee pain, Oxford, ROM, Overall satisfaction rate, Survivorship) | 24 |
Cho BW et al., 2020 [13] | Korea | Retrospective cohort | Persona | NexGen | Actual TKA | 59/78 58/74 | 9/50 4/54 | 71.2 ± 5.7 71.1 ± 6.2 | Underhang; Overhang; Revision rate; Clinical outcomes (VAS, KSS, WOMAC) | 31.9 ± 5.8 33.9 ± 11.5 |
Rhee SJ et al., 2018 [14] | Korea | RCT | Persona | NexGen | Actual TKA | NR/50 NR/51 | 4/46 7/44 | 67.3 ± 7.3 68.7 ± 7.2 | Rotation of the tibial component | 0.5 |
Jin C et al., 2016 [15] | Korea | Retrospective cohort | Persona | NexGen | Actual TKA | 100/100a | 9/91a | 71(56–83)a,b | Coverage rate; Underhang; Overhang; | None |
Shaet s al, 2015 [16] | India | RCT | Genesis II | NexGen | Virtual TKA | 150/300a | 63/87a | 35.5(18–50)a,b | Coverage rate; Underhang; Overhang; | None |
Meier M et al., 2018 [17] | USA | Retrospective cohort | Persona | Sigma | Virtual TKA | 100/100a | 50/50a | 65.6(49–93) a,b | Coverage rate | None |
Stulberg SD et al., 2015 [18] | USA | Retrospective cohort | Persona | NexGen | Virtual TKA | 91/100a | 29/62a | 66.4(41–84) a,b | Coverage rate; Rotation of the tibial component; Malrotation | None |
Ma Y et al., 2017 [19] | Japan | Retrospective cohort | Persona | NexGen | Virtual TKA | 77/77a | 15/62a | NR | Overhang; Rotation of the tibial component | None |
Martin S et al., 2014 [20] | USA | Retrospective cohort | NR | NR | Virtual TKA | 30/30a | NR | NR | Coverage rate; Rotation of the tibial component; Malrotation | None |
Wernecke GC et al., 2012 [21] | Australia | Retrospective cohort | Genesis II | NexGen | Virtual TKA | 101/101a | 74/27a | 32(17–60) a,b | Coverage rate; Underhang; Overhang; | None |
Clary C et al., 2014 [22] | USA | Retrospective cohort | Genesis II | Sigma | Virtual TKA | 14,791/14791a | NR | NR | Coverage rate | None |
Miyatake N et al., 2016 [23] | Japan | Retrospective cohort | Genesis II | NexGen | Actual TKA | NR/92 NR/586 | 9/83 111/475 | 73.7 ± 6.7a | Underhang | None |
Maciag BM et al., 2021 [24] | Poland | Retrospective cohort | Persona | NexGen | Actual TKA | 39/39 34/34 | 13/26 12/22 | 68.6 ± 6.3 69.5 ± 5.7 | Underhang; Overhang; | 1.5 |
Bizzozero P et al., 2018 [25] | France | Retrospective cohort | Persona | NexGen | Actual TKA | 33/33 33/33 | 15/17 15/17 | 77(57–92)b 75(66–89)b | Coverage rate; Overhang; Rotation of the tibial component; Malrotation; Clinical outcomes (KSS) | 44 ± 5.4 46 ± 5.7 |